Vaginal microbiome dysbiosis in preterm birth.


Journal

Progress in molecular biology and translational science
ISSN: 1878-0814
Titre abrégé: Prog Mol Biol Transl Sci
Pays: Netherlands
ID NLM: 101498165

Informations de publication

Date de publication:
2022
Historique:
entrez: 24 10 2022
pubmed: 25 10 2022
medline: 27 10 2022
Statut: ppublish

Résumé

All the environmentally exposed surfaces of the human body harbor ecologically distinct microbial communities with a mutualistic beneficial relationship. Depending on the body sites, microbes may provide metabolic functions, protection against pathogens, and signaling molecules to modulate host physiology and reduce disease susceptibility. Our recent understanding of the vaginal microbiome based on culture-independent 16S rRNA gene sequencing indicates that Lactobacillus-dominated microbial communities of healthy women play an important role in decreasing susceptibility to several urogenital diseases, including bacterial, fungal and viral infections. The findings of shotgun sequencing of the vaginal microbiome suggest that microbial-derived lactic acid, bacteriostatic, bactericidal molecules, and lower vaginal pH mediate such protections and regulations. Bacterial species, the dominant component of the vaginal microbiome, also play a key role in determining the gestation period and birth outcomes of reproductive-age women. The presence of Lactobacillus crispatus species in the vaginal milieu reduces the risk of preterm delivery in women of Asian ancestry. A deeper knowledge of the vaginal microbiota's role in the succession and development of newborn gut bacteria would also be beneficial. The microbiome of the mother changes throughout pregnancy and is linked to the microbiome of the newborn. This chapter highlights updated information and new opportunities for human microbiome research, focusing on the assessment of the risk of preterm birth.

Identifiants

pubmed: 36280323
pii: S1877-1173(22)00125-9
doi: 10.1016/bs.pmbts.2022.08.001
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0
Lactic Acid 33X04XA5AT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-329

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Taruna Ahrodia (T)

Molecular Genetics Laboratory, Infection and Immunology Division, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India.

J R Yodhaanjali (JR)

Molecular Genetics Laboratory, Infection and Immunology Division, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India.

Bhabatosh Das (B)

Molecular Genetics Laboratory, Infection and Immunology Division, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India. Electronic address: bhabatosh@thsti.res.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH